Policy regarding weight management medication (tirzepatide, brand name Mounjaro) in Lancashire and South Cumbria

NHS Lancashire and South Cumbria Integrated Care Board (ICB) has approved its policy regarding the prescription of tirzepatide (Mounjaro).

GP practices will identify their patients who are eligible, based on criteria set by the ICB, to receive the medication and contact them directly.

Who is eligible?

The first group of people eligible are those who:

• Live in an area identified as one of the most deprived based on the Government’s indices of multiple deprivation (IMD-1).
• Have a body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds) 

And have at least four of the following long-term conditions: 

• Non-diabetic hyperglycaemia or type two diabetes
• Hypertension (high blood pressure)
• Dyslipidaemia
• Established cardiovascular disease
• Obstructive sleep apnoea (formally diagnosed)

The NHS has an obligation to commission services equitably, ensuring fair access to health support for those most in need. As NHS funds are limited, we are targeting this support initially at those from the most deprived areas of the region.

Please do not contact your GP to request medication. If you are eligible, you will be contacted directly.